Production of matrix metalloproteinases by cultured bovine theca and granulosa cells

Reproduction

Volumn 129, Issue 1, 2005, Pages 75-87

  Smith, M F ^c   Gutierrez, C G ^a,e   Ricke, W A ^c,d   Armstrong, D G ^a   Webb, R ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; ANDROSTENEDIONE; CASEIN; ESTRADIOL; FOLLITROPIN; GELATIN; GELATINASE A; GELATINASE B; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME RELEASE; ESTRUS CYCLE; EXTRACELLULAR MATRIX; FEMALE; GRANULOSA CELL; HORMONE SYNTHESIS; IMAGE ANALYSIS; LUTEINIZATION; MOLECULAR SIZE; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; THECA CELL; TIME; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; GRANULOSA CELLS; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; THECA CELLS;

EID: 12744261273     PISSN: 14701626     EISSN: None     Source Type: Journal    
DOI: 10.1530/rep.1.00381     Document Type: Article

References (44)

1. Armstrong DG & Webb R 1997 Ovarian follicular dominance: novel mechanisms and protein factors. Reviews of Reproduction 2 139-146.
2. Bagavandoss P 1998 Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. Journal of Endocrinology 158 221-228.
3. Bao B, Garverick H, Smith G, Smith M, Salfen B & Youngquist R 1997 Changes in messenger ribonucleic acid encoding luteinizing hormone receptor, cytochrome P450-side chain cleavage, and aromatase are associated with recruitment and selection of bovine ovarian follicles. Biology of Reproduction 56 1158-1168.
4. Barrett AJ & Starkey PM 1973 The interaction of alpha 2-macrogloublin with proteases: Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochemical Journal 133 709-724.
5. Beers WH 1975 Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 6 379-386.
6. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z & Hanahan D 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology 2 737-744.
7. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 1157-1164.
8. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP & Cheresh DA 1996 Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 683-693.
9. Brooks PC, Silletti S, von Schalscha TL, Friedlander M & Cheresh DA 1998 Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92 91-400.
10. Campbell BK, Baird DT & Webb R 1998 Effects of dose of LH on androgen production and luteinization of ovine theca cells cultured in a serum-free system. Journal of Reproduction and Fertility 112 69-77.
11. Cooke RG, Nothnick WB, Komar C, Burns P & Curry TE 1999 Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary. Biology of Reproduction 61 1309-1316.
12. Coussens LM, Tinkle CL, Hanahan D & Werb Z 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 481-490.
13. 2-Macroglobulin and tissue inhibitor of metalloproteinases: Collagenase inhibitors in human preovulatory ovaries. Endocrinology 127 63-68.
14. Curry TE Jr, Song L & Wheeler SE 2001 Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biology of Reproduction 65 855-865.
15. Curry TE Jr & Osteen KG 2003 The matrix metalloproteinase system: Changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrine Reviews 24 428-465.
16. Dow MP, Bakke LJ, Cassar CA, Peters MW, Pursley JR & Smith GW 2002 Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biology of Reproduction 66 1413-1421.
17. Egeblad M & Werb Z 2002 New functions for the matrix metalloproteinases in cancer progression. Nature Reviews 2 163-176.
18. Fields M & Fields P 1996 Morphological characteristics of the bovine corpus luteum during the estrous cycle and pregnancy. Theriogenology 45 1295-1325.
19. Flaumenhaft R & Rifkin DB 1992 The extracellular regulation of growth factor action. Molecular Biology of Cell 3 1057-1065.
20. 2-macroglobulin in rat ovarian follicles and corpora lutea. Endocrinology 125 2985-2995.
21. Giancotti FG 1997 Integrin signaling: specificity and control of cell survival and cell cycle progression. Current Opinion in Cell Biology 9 691-700.
22. Gutiérrez CG, Campbell BK & Webb R 1997 Development of a long-term bovine granulosal cell culture system: Induction and maintenance of estradiol production, response to follicle-stimulating hormone, and morphological characteristics. Biology of Reproduction 56 608-616.
23. Jimenez-Krassel F, Winn M, Ireland JLH & Ireland JJ 2002 Evidence for an intrafollicular role of alpha-2-macroglobulin in regulation of estradiol production. Journal of Animal Science 80 300.
24. Kennedy III JL, Muse KN, Keeble SC & Curry TE Jr 1996 Hormonal regulation of tissue inhibitors of metalloproteinases during follicular development in the rat ovary. Endocrine 5 299-305.
25. Kubler B, Cowell S, Zapf J & Braulke T 1998 Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum. Endocrinology 139 1556-1563.
26. Li M, Karakji EG, Xing R, Fryer JN, Carnegie JA, Rabbani SA & Tsang BK 1997 Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development. Endocrinology 138 2790-2799.
27. Logan A & Hill DJ 1992 Bioavailability: Is this a key event in regulating the actions of peptide growth factors? Journal of Endocrinology 134 157-161.
28. Luck MR 1994 The gonadal extracellular matrix. Oxford Reviews of Reproductive Biology 16 34-85.
29. Nagase H & Okada Y 1997 Proteinases and matrix degradation. in Textbook of Rheumatology, pp 323-341. Ed. W Kelley. Philadelphia: WB Saunders.
30. 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. In Inhibition of Matrix Metalloproteinases: Therapeutic Potential, pp 294-302. Eds RA Greenwald & LM Golub. New York: The New York Academy of Sciences.
31. Nagase H & Woessner JF Jr 1999 Matrix metalloproteinases. Journal of Biological Chemistry 274 21491-21494.
32. Oksjoki S, Sallinen S, Vuorio E & Anttila L 1999 Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary. Molecular Human Reproduction 5 803-808.
33. Redmer DA, Grazul AT, Kirsch JD & Reynolds LF 1988 Angiogenic activity of bovine corpora lutea at several stages of luteal development. Journal of Reproduction and Fertility 82 627-634.
34. Ricke WA, Smith GA, Reynolds LP, Redmer DA & Smith MF 2002 Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle. Biology of Reproduction 66 1083-1094.
35. Rifkin DB, Mazziere R, Munger JS, Noguera I & Sung J 11999 Proteolytic control of growth factor availability. APMIS 107 80-85.
36. Rodgers RJ, van Wezel IL, Irving-Rodgers HF, Lavranos TC, Irvine CM & Krupa M 1999 Roles of extracellular matrix in follicular development. Journal of Reproduction and Fertility Supplement 54 343-352.
37. Smith MF, McIntush EW, Ricke WA, Kojima FN & Smith GW 1999 Regulation of ovarian extracellular matrix remodeling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. Journal of Reproduction and Fertility Supplement 54 367-381.
38. Smith MF, Ricke WA, Bakke LJ, Dow MPD & Smith GW 2002 Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors. Molecular and Cellular Endocrinology 191 45-56.
39. Taipale J & Keski-Oja J 1997 Growth factors in the extracellular matrix. FASEB Journal 11 51-59.
40. Tamura T, Nakanish T, Kimura Y, Hattori T, Sasaski K, Norimatsu H, Takahashi K & Takigawa M 1996 Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137 3729-3737.
41. Toth M, Hernandez-Barrantes S, Osenkowski P, Bernardo MM, Gervasi DC, Shimura Y, Meroueh O, Kotra LP, Gálvez BG, Arroyo AG, Mobashery S & Fridman R 2002 Complex pattern of membrane type 1 matrix metalloproteinase shedding. Journal of Biological Chemistry 277 26340-26350.
42. Tremble P, Damski CH & Werb Z 1995 Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. Journal of Cell Biology 129 1707-1720.
43. van Wezel IL & Rodgers RJ 1996 Morphological characterization of bovine primordial follicles and their environment in vivo. Biology of Reproduction 55 1003-1011.
44. Zhang B, Yan L, Moses MA & Tsang PCW 2002 Bovine membrane-type 1 matrix metalloproteinases: Molecular cloning and expression in the corpus luteum. Biology of Reproduction 67 99-106.